OpenText CEO to undergo treatment for leukemia
TORONTO (Reuters) - Canadian business-software maker OpenText Corp said on Monday its Chief Executive Mark Barrenechea has been diagnosed with leukemia, and that he will reduce his involvement in the day-to-day operations while he undergoes treatment over the next three months.
Waterloo, Ontario-based OpenText, whose software helps companies manage documents and workflows, said a CEO operating committee has been established to assist in the management of the company's day-to-day operations while Barrenechea receives treatment.
In addition to Barrenechea, the committee will consist of John Doolittle, who is OpenText's chief financial officer, and Gordon Davies, its chief legal officer.
(Reporting by Euan Rocha; editing by Andrew Hay)
© Thomson Reuters 2017 All rights reserved.